Generics Bulletin
HBW Insight
In Vivo
Medtech Insight
Pink Sheet
Scrip
Close
Search
Search
Generics Bulletin
HBW Insight
In Vivo
Medtech Insight
Pink Sheet
Scrip
EMA Lays Out Plans For Routine Use Of Real-World Evidence
EU Draft Artificial Intelligence Guideline Slated For November 2022
Sep 03 2021
•
By
Vibha Sharma
Regulators will increasingly use insights derived from big data to assess the benefit-risk of medicines • Source: Alamy
More from Real-World Evidence
More from Clinical Trials